查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405751

鬱血性心臟衰竭治療設備市場規模、佔有率、趨勢分析報告：按產品、按地區、細分市場預測，2023-2030 年

Congestive Heart Failure Treatment Devices Market Size, Share & Trends Analysis Report By Product (Ventricular Assist Devices, Counter Pulsation Devices, Pacemakers), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10個工作天內

價格

鬱血性心臟衰竭治療設備市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球鬱血性心臟衰竭器材市場規模將達到465.8億美元，2023年至2030年複合年成長率為7.6%。

CVD負擔的增加是導致該行業利潤豐厚成長的主要因素之一。久坐的生活方式、精神壓力和食用垃圾食物的傾向是心血管疾病發生的主要因素。

美國醫療保險制度等有利的報銷政策被視為該行業的主要成長要素。該公司現在提供新產品平台，並提供有利於患者的折扣。報銷適用於治療 CHF 的設備，輔助人工心臟(VAD)、植入式心臟整流去顫器(ICD) 和心律調節器。

行業相關人員專注於開發能夠提供個體化護理的高度實用的產品。這些進步提供了額外的功能來提高準確性、增強工作流程並降低錯誤率。

鬱血性心臟衰竭治療設備市場報告亮點

  • 市場依產品細分為輔助人工心臟、反搏裝置、ICD、心律調節器和心臟再同步裝置。 ICD領域包括經靜脈和皮下兩種類型，將在2022年佔據有利的市場佔有率，其次是起搏器領域。這是因為心臟去顫器和心律調節器是心臟衰竭的第一線治療方法。
  • 另一方面，由於保險報銷範圍和輔助人工心臟的技術進步，預計輔助人工心臟（VAD）領域在預測期內將出現強勁成長。
  • 輔助人工心臟依植入部位分為左心室輔助人工心臟（LVAD）及右心室輔助人工心臟（RVAD）。當 LVAD 和 RVAD 一起植入時，它們被稱為雙心室輔助裝置 (BIVAD)。
  • 北美地區在整個市場中佔據主導地位，2022 年收益佔有率將超過 40.55%。這是由於受CVD影響的人口基數大以及老年人口基數大。
  • 市場參與企業正在積極努力改進其當前的產品系列，以保持其市場地位。此外，藥物開拓和進入開拓國家的市場預計將推動市場成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章鬱血性心臟衰竭治療設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 鬱血性心臟衰竭治療設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章鬱血性心臟衰竭治療設備市場：產品評估與趨勢分析

  • 鬱血性心臟衰竭治療設備市場：重點
  • 鬱血性心臟衰竭治療設備市場：2022 年和 2030 年產品變化和市場佔有率分析
  • 鬱血性心臟衰竭輔助裝置（VAD）
  • 反搏裝置
  • 植入式心臟整流去顫器
  • 起搏器
  • 心臟再同步治療

第5章鬱血性心臟衰竭設備市場：區域估計與趨勢分析

  • 區域展望
  • 鬱血性心臟衰竭治療設備市場（按地區）：市場要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第6章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Jarvik Heart Inc.
    • ReliantHeart, Inc.
    • Biotronik SE & Co. KG
    • Berlin Heart GmbH
    • Abbott (St. Jude Medical)
    • Medtronic
    • Boston Scientific Corporation
    • Teleflex, Inc.
Product Code: GVR-1-68038-292-1

Congestive Heart Failure Treatment Devices Market Growth & Trends:

The global congestive heart failure treatment devices market size is expected to reach USD 46.58 billion by 2030, registering a CAGR of 7.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs.

Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.

The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.

Congestive Heart Failure Treatment Devices Market Report Highlights:

  • The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2022, which was followed by the pacemaker's segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
  • On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
  • The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
  • North America dominated the overall market in terms of revenue share at over 40.55% in 2022; this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
  • The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. CHF Treatment Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. CHF Treatment Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. CHF Treatment Devices Market: Product Estimates & Trend Analysis

  • 4.1. CHF Treatment Devices Market: Key Takeaways
  • 4.2. CHF Treatment Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Ventricular Assist Devices (VADs)
    • 4.3.1. Ventricular Assist Devices (VADs) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Counter Pulsation Devices
    • 4.4.1. Counter pulsation devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Implantable Cardioverter Defibrillators
    • 4.5.1. Implantable cardioverter defibrillators market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Pacemakers
    • 4.6.1. Pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Cardiac Resynchronization Therapy
    • 4.7.1. Cardiac resynchronization therapy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. CHF Treatment Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. CHF Treatment Devices Market by Region: Key Marketplace Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Jarvik Heart Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. ReliantHeart, Inc.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Biotronik SE & Co. KG
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Berlin Heart GmbH
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Abbott (St. Jude Medical)
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Medtronic
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Boston Scientific Corporation
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Teleflex, Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 France CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 China CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 India CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait CHF treatment devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 CHF treatment devices: market outlook
  • Fig. 9 CHF treatment devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 CHF treatment devices market driver impact
  • Fig. 15 CHF treatment devices market restraint impact
  • Fig. 16 CHF treatment devices market strategic initiatives analysis
  • Fig. 17 CHF treatment devices market: Product movement analysis
  • Fig. 18 CHF treatment devices market: Product outlook and key takeaways
  • Fig. 19 Ventricular Assist Devices (VADs) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 LVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 RVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 BiVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Counter Pulsation Devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Implantable Cardioverter Defibrillators market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Transvenous ICD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Subcutaneous ICD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Implantable pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 External pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Cardiac Resynchronization therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Cardiac Resynchronization Therapy-Defibrillators (CRT-D) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Global CHF treatment devices market: Regional movement analysis
  • Fig. 34 Global CHF treatment devices market: Regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)